The Journal of Stem Cell Therapy and Transplantation (JSCTT) is dedicated to maintaining the highest ethical standards in publishing stem cell research and clinical applications. Authors submitting manuscripts must adhere to ethical guidelines that ensure transparency, integrity, and credibility in stem cell science and regenerative medicine.

Authorship and Contribution

All authors listed on a manuscript should have made significant contributions to the research and writing process. Authors must:

• Substantially contribute to the conception, design, experimentation, or analysis of the study.
• Be involved in drafting, reviewing, or revising the manuscript critically.
• Approve the final version before submission.
• Agree to be accountable for the integrity and accuracy of the research.

Individuals who contributed to the research but do not meet authorship criteria should be acknowledged appropriately.

Originality and Plagiarism

The JSCTT upholds strict policies against plagiarism and duplicate publication. Authors must:

• Ensure their manuscript is original and free from plagiarism.
• Properly cite and credit all sources, including figures, tables, and datasets.
• Refrain from submitting the same manuscript to multiple journals simultaneously.
• Avoid self-plagiarism by properly referencing their own previously published work.

Plagiarism in any form, including data fabrication or falsification, will lead to immediate rejection or retraction.

Data Integrity and Reproducibility

Authors are responsible for ensuring the accuracy and reproducibility of their research findings. The journal expects:

• Raw data to be available for editorial review if requested.
• Proper documentation of experimental procedures, stem cell sourcing, and statistical analysis.
• Transparency in clinical trial data, cell differentiation protocols, and genetic modifications.

Any manipulation or fabrication of data will be considered a serious ethical violation.

Conflicts of Interest

All authors must disclose any potential conflicts of interest that could influence their research findings, including:

• Financial relationships with biotechnology companies, pharmaceutical firms, or funding agencies.
• Personal or professional affiliations that may bias the study.
• Any external funding received for the research.

Failure to disclose conflicts of interest may result in retraction or rejection of the manuscript.

Ethical Approval and Compliance

For research involving human or animal stem cells, authors must:

• Obtain approval from an institutional review board (IRB) or ethics committee.
• Ensure compliance with international guidelines such as the Declaration of Helsinki, ISSCR Guidelines for Stem Cell Research and Clinical Translation, and national regulations.
• Clearly describe any ethical considerations, including patient consent, donor sourcing, and stem cell derivation methods.

Failure to meet ethical approval standards will result in manuscript rejection.

Human and Animal Stem Cell Research Guidelines

The JSCTT enforces strict ethical guidelines for stem cell research. Authors must:

• Ensure that human embryonic stem cell (hESC) research complies with national and institutional ethical standards.
• Obtain proper consent for all human stem cell samples, including induced pluripotent stem cells (iPSCs).
• Avoid research that involves unapproved clinical use of stem cell therapies.
• Follow the ARRIVE guidelines for reporting animal research involving stem cells.

Manuscripts that do not meet these ethical standards will not be considered for publication.

Patient Confidentiality and Consent

The JSCTT requires authors to respect patient confidentiality and informed consent in all clinical research. Authors must:

• Obtain written consent from patients or donors for studies involving human subjects or tissue samples.
• Anonymize identifying details (e.g., names, images, and genetic information) unless explicit consent is provided.
• Ensure compliance with HIPAA, GDPR, or other data protection regulations.

Failure to meet these requirements will result in manuscript rejection.

Corrections and Retractions

The JSCTT maintains a policy for correcting errors and addressing ethical concerns. Authors must:

• Inform the journal immediately if they discover significant errors in their published work.
• Cooperate with the editorial board in issuing corrections or retractions when necessary.
• Report any suspected research misconduct related to their study.

Articles found to contain ethical violations or unreliable findings may be subject to retraction.

Submission Declaration

By submitting a manuscript to the JSCTT, authors confirm that:

• The manuscript has not been submitted or published elsewhere.
• All co-authors have reviewed and approved the submission.
• The work complies with ethical research and publication guidelines.

For any ethical concerns or clarifications, authors are encouraged to contact the editorial office.